August 28, 2023 02:56 PM EDT
Pharma

ABPI, re­searchers crit­i­cize NHS’ In­no­v­a­tive Med­i­cines Fund, with no new ther­a­pies avail­able over a year af­ter for­ma­tion

Katherine Lewin

News Reporter

Two years ago, the UK’s Na­tion­al Health Ser­vice an­nounced the cre­ation of the In­no­v­a­tive Med­i­cines Fund (IMF), de­signed to cov­er the cost of new rare …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er ends work on Sang­amo's he­mo­phil­ia gene ther­a­py, crush­ing biotech's hopes

Flag­ship biotech Va­lo Health ends 2024 with mid-stage fail

No­var­tis ends Phase 1 ra­dio­phar­ma tri­al; Solve Ther­a­peu­tics pur­sues $75M round

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves sub­cu­ta­neous ver­sion of Bris­tol My­er­s' Op­di­vo

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

A service from the Financial Times